Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $91.7700 (-1.96%) ($91.2600 - $94.2000) on Thu. Aug. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.69% (three month average) | RSI | 31 | Latest Price | $91.7700(-1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -3.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.345% in a week (0% probabilities). VIXM(-33%) VXX(-21%) TLT(-15%) IFRA(-9%) UUP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.345% (StdDev 2.69%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
Resistance Level | $98.31 | 5 Day Moving Average | $92.88(-1.2%) | 10 Day Moving Average | $92.49(-0.78%) | 20 Day Moving Average | $98.31(-6.65%) | To recent high | -23.6% | To recent low | 2.5% | Market Cap | $1.475b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |